BSE · 544205
National Peroxide Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹291 Cr with net profit ₹-2 Cr — a -0.77% net margin, versus 4.97% the period before.
Shareholding
As of 2026-06-30
- Promoter70.76%
- Public29.23%
- DII0.01%
15,292 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.05× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ESM · ESM 1. Trading may carry price bands, periodic call auction or higher margins.
- Reported zero revenue in 2 of the last 5 disclosed periods.
Peer comparison
Chemicals · ranked #81 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Pidilite Industries Ltd. | ₹1,66,203 Cr | 286.99 | 15.34 | 22.61% | 16.77% |
| Solar Industries India Ltd. | ₹1,63,552 Cr | 298.65 | 26.06 | 26.72% | 17.05% |
| SRF Ltd. | ₹78,434 Cr | 134.79 | 5.59 | 13.07% | 11.9% |
| Linde India Limited | ₹57,119 Cr | 737.61 | 13.39 | 12.48% | 0.18% |
| Gujarat Fluorochemicals Ltd. | ₹50,111 Cr | 459.86 | 6.42 | 7.3% | 11.49% |
| Godrej Industries Ltd. | ₹43,596 Cr | 98.13 | 3.9 | 11.1% | 5.58% |
| Navin Fluorine International Ltd. | ₹38,803 Cr | 182.32 | 9.75 | 16.69% | 20.02% |
| Himadri Speciality Chem Limited | ₹38,633 Cr | 192.39 | 8.21 | 15.96% | 16.12% |
| Deepak Nitrite Ltd. | ₹22,924 Cr | 104.33 | 3.93 | 9.43% | 6.98% |
| Deepak Fertilisers & Petrochemicals Corp Ltd. | ₹20,733 Cr | 148.77 | 3.03 | 10.77% | 6.41% |
| National Peroxide Limited(this company) | ₹332 Cr | 28.92 | 0.92 | 3.05% | 3.81% |
AI analysis
AI-generated · google/gemini-2.5-flashNational Peroxide Limited has a market capitalization of Rs 339 Cr. The company reported revenue of Rs 291.36 Cr and a net profit of Rs -2.2464 Cr in March 2025. Its PE ratio is 29.53 and EPS is 19.98. The book value per share is Rs 629.92.
Positives
- +The company has a low debt-to-equity ratio of 0.05.
- +Return on equity (ROE) was 304.9%.
- +Promoter holding is high at 70.7614% as of March 2026.
Negatives
- −Revenue declined from Rs 338.1495 Cr in March 2024 to Rs 291.3611 Cr in March 2025.
- −The company reported a net profit of -2.2464 Cr in March 2025, down from 16.7903 Cr in March 2024.
- −The company is currently under ESM surveillance.
Financial performance
National Peroxide Limited's revenue decreased from Rs 384.7286 Cr in March 2023 to Rs 291.3611 Cr in March 2025. Net profit also declined from Rs 39.5016 Cr in March 2023 to Rs -2.2464 Cr in March 2025. Quarterly revenue has shown some fluctuations, with Rs 85.68 Cr reported in March 2026.
Profitability & returns
The company reported a profit margin of 381.1%. Return on equity (ROE) was 304.9% and return on capital employed (ROCE) was 4.2109%. Earnings per share (EPS) was 19.98, though it was -3.91 in March 2025, recovering to 7.93 in March 2026.
Balance sheet
National Peroxide Limited has a debt-to-equity ratio of 0.05, indicating a low level of debt. The company's book value per share is Rs 629.92.
Ownership & pledges
There were no promoter pledges reported. The number of shareholders was 15470 in March 2026, slightly down from 15811 in December 2025.
Regulatory & surveillance
National Peroxide Limited is under ESM surveillance, specifically ESM 1, with measures including ESM.
Data as of — price: 2026-07-29 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.